Surgery for liver metastases from breast cancer.
Liver metastases from breast cancer (BCLM) confer poor survival. Liver resection in BCLM patients has been increasingly employed. We undertook a systematic review to evaluate the role of hepatic resection in patients with breast cancer metastatic to the liver. In total, 36 studies were overviewed. Patient populations, characteristics, morbidity, mortality and survival were documented. Median overall survival was 41 months. Major morbidity was rare while 30-day postoperative mortality was near nil. Liver surgery for BCLM can be performed with low mortality, acceptable morbidity and promising survival benefit in carefully selected patients.